VC-backed JenaValve beefs up Munich team with new hire

By Iris Dorbian — 3 weeks ago

JenaValve Technology Inc, a maker of transcatheter aortic valve replacement systems, has named Pieter Van den Steen as chief commercial officer and general manager of the company’s Munich office. Previously, Van den Steen worked at Boston Scientific. JenaValve’s backers included Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management, Omega Funds, RMM, Sunstone Capital, Valiance and VI Partners.

Continue

JenaValve scores $26.5 mln Series C

By Iris Dorbian — 6 months ago

JenaValve Technology Inc, a maker of transcatheter aortic valve repair solutions, has closed $26.5 million in Series C funding. RMM and Valiance led the round with participation from other investors that included Atlas Venture, Edmond de Rothschild Investment Partners, Gimv, Legend Capital, NeoMed Management and VI Partners.

Continue

InnoSpring raises $5 mln for Fund II

By Luisa Beltran — 8 months ago

InnoSpring said Monday that its most recent fund closed at $5 million. Investors of InnoSpring Seed Fund II include Legend Capital, IDG Capital Partners, Softbank China Capital, Legend Star Fund by Legend Holdings, The Chinese Software Developer Network (CSDN), the largest developer community in China, as well senior executives from China internet giant Tencent. Santa Clara-based InnoSpring focuses on sectors such as mobile first consumer technology, enterprise software, FinTech and HealthTech startups.

Continue

BioNano Genomics scores $53 mln Series C

By Iris Dorbian — 1 year ago

San Diego-based BioNano Genomics, a provider of genome mapping, has closed $53 million in Series C financing. Legend Capital and Novartis Venture Fund led the round with participation from Federated Kaufmann Fund, Monashee Investment Management, Domain Associates, Battelle Ventures and Gund Investment Corp. In conjunction with the funding, Dr. Darren Cai of Legend Capital and Dr. Campbell Murray of Novartis Venture Fund have been added to BioNano’s board of directors.

Continue

VC-backed JenaValve Technology hires CEO

By Iris Dorbian — 2 years ago

JenaValve Technology said Monday that it has named David J. Drachman as CEO. The appointment is effective immediately. Drachman is the former president and CEO of AtriCure. Based in Munich, Germany and Irvine, Calif., JenaValve Technology is a provider of transcatheter aortic valve implantation systems that treat aortic valve disease. Its backers include Atlas Venture, Edmond de Rothschild Investment Partners, GIMV, NeoMed Management, Legend Capital, VI Partners, Sunstone Capital, Omega Funds, Biovest and Valiance Advisors.

Continue

JenaValve Technology snags $10 mln Series C funds

By Iris Dorbian — 2 years ago

JenaValve Technology has closed $10 million in Series C funding. Investors included Valiance Asset Management, RMM, Edmond de Rothschild Investment Partners, Atlas Venture Fund, NeoMed Management, Legend Capital and Omega Funds. Based in Munich, Germany, JenaValve Technology is a provider of transcatheter aortic valve implantation systems to treat patients suffering from aortic valve disease.

Continue

Axonics Modulation Technologies nabs $32.6 mln Series A funds

By Iris Dorbian — 2 years ago

Axonics Modulation Technologies has closed $32.6 million in Series A financing. Edmond de Rothschild Investment Partners led the round with participation from NeoMed Management, Legend Capital and various private investors. In conjunction with the funding, Raphaël Wisniewski of EdRIP, Erik Amble of NeoMed and Darren Cai of Legend have been added to Axonics’ board of directors. Based in Irvine, Calif., Axonics Modulation Technologies is a maker of novel implantable neuromodulation technology.

Continue

Slideshow: Bring on the 2012 IPO Candidates

By Joanna Glasner — 4 years ago

The market for venture-backed IPOs has been pretty dead so far this year. But based on new filing activity, it looks like there’s some optimism things will improve. At least six venture-backed companies have filed to go public since the start of the year, in sectors ranging from enterprise software to semiconductors to car rentals. […]

Continue

Happy Elements Seals $30M

4 years ago

Chinese social gaming company Happy Elements has closed a $30 million Series B round led by Legend Capital with participation from existing investor DCM. The money will be used to expand into new markets, and to launch several new smartphone games in the next year. Two-year-old Happy Elements has roughly 300 employees and is based in Beijing.

Continue

Pharmaron Closes $40M Series C

5 years ago

Pharmaron Holding Limited has closed a $40 million Series C round. Existing investors DCM and Legend Capital joined new investor GL Capital Group in the round, which will be used to expand the company’s drug discovery services, toxicology capabilities and chemical synthesis services. Pharmaron was formed in 2003, and provides research and development services to the biotech and pharmaceutical industries.

Continue

Bonovo Orthopedics Inks $10M Series C

5 years ago

U.S. and China-based Bonovo Orthopedics has raised $10 million in a Series C financing led by OrbiMed Asia Partners. The round, which includes participation from Beijing-based Legend Capital, brings the company’s total financing to $16.5 million. Bonovo will use the money to expand its sales and continue product development. Formed in 2008, Bonovo manufactures implants and other orthopedic products for the Chinese healthcare market.

Continue

Venture-backed Oak Pacific Interactive Mulls IPO

5 years ago

Chinese social networking company Oak Pacific Interactive, which has raised more than $430 million in venture capital, is considering an initial public offering in the United States, Reuters reported. The company hired Credit Suisse Group and Deutsche Bank to underwrite its IPO slated for the first half of next year, Reuters said. Oak Pacific Interactive is backed by Technology Crossover Ventures, Accel Partners, Legend Capital, Softbank, Joho Capital, General Atlantic and Doll Capital Management.

Continue

Legend Capital Aims to raise $500M in New Funds

5 years ago

China-focused Legend Capital is planning to raise at least $500 million across two new funds next year: a 1 billion ($150 million) yuan-denominated fund and a $350 million U.S. dollar fund, Reuters reported. The new funds will look for deals that would benefit from government support, in sectors including telecommunications, green energy and pharmaceuticals, Reuters said.

Continue

Virtuos Buys Besides Sound Production

By PEHub Administrator — 7 years ago

Virtuos, a Beijing-based provider of videogame production services, has acquired Besides Sound Production, a Shanghai-based provider of audio production for videogames. No financial terms were disclosed. Virtuos is sponsored by Legend Capital.

Continue